Supplementary Table 1; Figures 1-4 from Synergistic Anticancer Activity of Arsenic Trioxide with Erlotinib Is Based on Inhibition of EGFR-Mediated DNA Double-Strand Break Repair
Open Access
- 3 April 2023
- other
- Published by American Association for Cancer Research (AACR)